Treatment of polypoidal choroidal vasculopathy with photodynamic therapy combined with intravitreal injections of ranibizumab

American Journal of Ophthalmology

Volumn 153, Issue 1, 2012, Pages

  Tomita, Kaoruko ^b   Tsujikawa, Akitaka ^a   Yamashiro, Kenji ^a   Ooto, Sotaro ^a   Tamura, Hiroshi ^a   Otani, Atsushi ^a   Nakayama, Yoshihito ^b   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nakano Eye Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARS PLANA VITRECTOMY; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETROSPECTIVE STUDY; SUBRETINAL HEMORRHAGE; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 83555174732     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.07.001     Document Type: Article

References (46)

1. P.J. Rosenfeld, D.M. Brown, J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
2. D.M. Brown, P.K. Kaiser, M. Michels Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
3. L.A. Yannuzzi, D.W. Wong, B.S. Sforzolini Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration Arch Ophthalmol 117 11 1999 1503 1510
4. L.A. Yannuzzi, A. Ciardella, R.F. Spaide, M. Rabb, K.B. Freund, D.A. Orlock The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy Arch Ophthalmol 115 4 1997 478 485
5. M. Uyama, T. Matsubara, I. Fukushima Idiopathic polypoidal choroidal vasculopathy in Japanese patients Arch Ophthalmol 117 8 1999 1035 1042
6. R.C. Kleiner, A.J. Brucker, R.L. Johnston The posterior uveal bleeding syndrome Retina 10 1 1990 9 17
7. R.M. Stern, Z.N. Zakov, H. Zegarra, F.A. Gutman Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women Am J Ophthalmol 100 4 1985 560 569
8. L.A. Yannuzzi, J. Sorenson, R.F. Spaide, B. Lipson Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina 10 1 1990 1 8
9. R.F. Spaide, L.A. Yannuzzi, J.S. Slakter, J. Sorenson, D.A. Orlach Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy Retina 15 2 1995 100 110
10. J.A. Wells, R. Murthy, R. Chibber Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation Br J Ophthalmol 80 4 1996 363 366
11. J.P. Tong, W.M. Chan, D.T. Liu Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 3 2006 456 462
12. M. Matsuoka, N. Ogata, T. Otsuji, T. Nishimura, K. Takahashi, M. Matsumura Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy Br J Ophthalmol 88 6 2004 809 815
13. M. Ghajarnia, S. Kurup, A. Eller The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy Semin Ophthalmol 22 2 2007 127 131
14. T.Y. Lai, W.M. Chan, D.T. Liu, F.O. Luk, D.S. Lam Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Br J Ophthalmol 92 5 2008 661 666
15. F. Gomi, M. Sawa, H. Sakaguchi Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy Br J Ophthalmol 92 1 2008 70 73
16. J.H. Song, S.H. Byeon, S.C. Lee, H.J. Koh, O.W. Kwon Short-term safety and efficacy of a single intravitreal bevacizumab injection for the management of polypoidal choroidal vasculopathy Ophthalmologica 223 2 2009 85 92
17. S.A. Pai, R. Shetty Sequential therapy with intravitreal bevacizumab and photodynamic therapy for idiopathic polypoidal choroidal vasculopathy Acta Ophthalmol 87 7 2009 806 807
18. S.Y. Lee, J.G. Kim, S.G. Joe, H. Chung, Y.H. Yoon The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy Korean J Ophthalmol 22 2 2008 92 99
19. M. Cho, I.A. Barbazetto, K.B. Freund Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy Am J Ophthalmol 148 1 2009 70 78
20. A.N. Stangos, J.S. Gandhi, J. Nair-Sahni, H. Heimann, C.J. Pournaras, S.P. Harding Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab Am J Ophthalmol 150 5 2010 666 673
21. A. Tsujikawa, S. Ooto, K. Yamashiro, H. Tamura, A. Otani, N. Yoshimura Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab Jpn J Ophthalmol 54 4 2010 310 319
22. G.T. Kokame, L. Yeung, J.C. Lai Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results Br J Ophthalmol 94 3 2010 297 301
23. A.A. Rouvas, T.D. Papakostas, A. Ntouraki, M. Douvali, I. Vergados, I.D. Ladas Photodynamic therapy, ranibizumab, and ranibizumab with photodynamic therapy for the treatment of polypoidal choroidal vasculopathy Retina 31 3 2011 464 474
24. C.K. Cheng, C.H. Peng, C.K. Chang, C.C. Hu, L.J. Chen One-year outcomes of intravitreal bevacizumab (Avastin) therapy for polypoidal choroidal vasculopathy Retina 31 5 2011 846 856
25. T. Hikichi, H. Ohtsuka, M. Higuchi Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months Am J Ophthalmol 150 5 2010 674 682
26. R.F. Spaide, I. Donsoff, D.L. Lam Treatment of polypoidal choroidal vasculopathy with photodynamic therapy Retina 22 5 2002 529 535
27. W.M. Chan, D.S. Lam, T.Y. Lai Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series Ophthalmology 111 8 2004 1576 1584
28. A. Otani, M. Sasahara, Y. Yodoi Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 144 1 2007 7 14
29. F. Gomi, M. Ohji, K. Sayanagi One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients Ophthalmology 115 1 2008 141 146
30. R.M. Silva, J. Figueira, M.L. Cachulo, L. Duarte, J.R. Faria de Abreu, J.G. Cunha-Vaz Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin Graefes Arch Clin Exp Ophthalmol 243 10 2005 973 979
31. Y. Kurashige, A. Otani, M. Sasahara Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 146 4 2008 513 519
32. D. Tsuchiya, T. Yamamoto, R. Kawasaki, H. Yamashita Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions Retina 29 7 2009 960 965
33. E. Akaza, R. Mori, M. Yuzawa Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy Retina 28 5 2008 717 722
34. M.R. Romano, U. Cipollone, F. Semeraro, M. Rinaldi, C. Costagliola Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up Clin Ophthalmol 4 2010 1237 1241
35. T. Sato, S. Kishi, H. Matsumoto, R. Mukai Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy Am J Ophthalmol 149 6 2010 947 954
36. F. Gomi, M. Sawa, T. Wakabayashi, Y. Sasamoto, M. Suzuki, M. Tsujikawa Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy Am J Ophthalmol 150 1 2010 48 54
37. C. Zuo, F. Wen, J. Li, Y. Liu, M. Li Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy Doc Ophthalmol 119 1 2009 29 36
38. S.W. Moon, M.S. Kim, E.S. Kim, S.Y. Yu, H.W. Kwak Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy Ophthalmologica 225 3 2011 169 175
39. P. Ruamviboonsuk, M. Tadarati, S. Vanichvaranont, P. Hanutsaha, N. Pokawattana Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study Br J Ophthalmol 94 8 2010 1045 1051
40. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update Retina 25 2 2005 119 134
41. K. Yamashiro, A. Tsujikawa, A. Nishida, M. Mandai, Y. Kurimoto Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy Jpn J Ophthalmol 52 6 2008 457 462
42. U. Schmidt-Erfurth, U. Schlötzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, G.O. Naumann Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 10 2003 4473 4480
43. Y. Sakurada, T. Kubota, M. Imasawa, F. Mabuchi, N. Tanabe, H. Iijima Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy Retina 30 10 2010 1616 1621
44. I. Nakata, K. Yamashiro, R. Yamada et al. Genetic variants in pigment epithelium-derived factor influence response of polypoidal choroidal vasculopathy to photodynamic therapy Ophthalmology 118 7 2011 1408 1415
45. Y. Hirami, A. Tsujikawa, A. Otani Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy Retina 27 3 2007 335 341
46. Y. Ojima, A. Tsujikawa, A. Otani, Y. Hirami, H. Aikawa, N. Yoshimura Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy Am J Ophthalmol 141 5 2006 958 960